KRW 13410.0
(-0.59%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 674.49 KRW | -50.82% |
2022 | 1371.39 KRW | -42.01% |
2021 | 2365.04 KRW | -13.19% |
2020 | 2724.46 KRW | 47.72% |
2019 | 1844.34 KRW | 12.68% |
2018 | 1636.78 KRW | 5.64% |
2017 | 1549.41 KRW | 54.08% |
2016 | 1005.62 KRW | 2486.47% |
2015 | 38.88 KRW | 108.99% |
2014 | -432.58 KRW | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 183.44 KRW | -21.38% |
2024 Q1 | 233.32 KRW | 10952.09% |
2023 FY | - KRW | -50.82% |
2023 Q1 | 220.09 KRW | 95.91% |
2023 Q2 | 259.94 KRW | 18.11% |
2023 Q3 | 195.74 KRW | -24.7% |
2023 Q4 | -2.15 KRW | -101.1% |
2022 FY | - KRW | -42.01% |
2022 Q4 | 112.34 KRW | -65.89% |
2022 Q3 | 329.31 KRW | -33.74% |
2022 Q2 | 497.03 KRW | 14.86% |
2022 Q1 | 432.71 KRW | -29.34% |
2021 Q2 | 583.88 KRW | -19.21% |
2021 Q3 | 446.07 KRW | -23.6% |
2021 FY | - KRW | -13.19% |
2021 Q1 | 722.73 KRW | 30.86% |
2021 Q4 | 612.36 KRW | 37.28% |
2020 FY | - KRW | 47.72% |
2020 Q4 | 552.28 KRW | -10.29% |
2020 Q3 | 615.63 KRW | -33.95% |
2020 Q2 | 932.04 KRW | 49.24% |
2020 Q1 | 624.52 KRW | 54.19% |
2019 Q2 | 524.25 KRW | 15.88% |
2019 Q1 | 452.40 KRW | -12.69% |
2019 FY | - KRW | 12.68% |
2019 Q4 | 405.03 KRW | -12.4% |
2019 Q3 | 462.36 KRW | -11.81% |
2018 Q2 | 357.70 KRW | 1.32% |
2018 Q1 | 353.03 KRW | 30.75% |
2018 Q3 | 407.89 KRW | 14.03% |
2018 FY | - KRW | 5.64% |
2018 Q4 | 518.15 KRW | 27.03% |
2017 FY | - KRW | 54.08% |
2017 Q2 | 652.08 KRW | 119.68% |
2017 Q1 | 296.83 KRW | 70.71% |
2017 Q4 | 270.00 KRW | -18.18% |
2017 Q3 | 330.00 KRW | -49.39% |
2016 Q2 | 279.00 KRW | 3.33% |
2016 FY | - KRW | 2486.47% |
2016 Q4 | 173.88 KRW | -38.56% |
2016 Q3 | 283.00 KRW | 1.43% |
2016 Q1 | 270.00 KRW | 344.15% |
2015 Q4 | 60.79 KRW | -89.13% |
2015 Q3 | 559.00 KRW | 231.32% |
2015 Q2 | 168.72 KRW | 126.92% |
2015 Q1 | -626.86 KRW | 0.0% |
2015 FY | - KRW | 108.99% |
2014 FY | - KRW | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
NeoPharm CO., LTD. | 1484.00 KRW | 54.549% |